{"title":"特比萘芬治疗后结节性红斑1例报告","authors":"Raghu Vasanthan","doi":"10.46889/jdr.2023.4104","DOIUrl":null,"url":null,"abstract":"Terbinafine is a commonly used anti-fungal agent in dermatological practice but not one clearly associated with erythema nodosum. There is only one published report in 2014 that described a delayed onset of erythema nodosum after cholestasis complicated terbinafine therapy. We report the case of a woman who developed erythema nodosum whilst on terbinafine therapy for onychomycosis to further consider this link and its potential implications.","PeriodicalId":15448,"journal":{"name":"Journal of clinical & experimental dermatology research","volume":"63 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Erythema Nodosum Associated with Terbinafine Therapy- A Case Report\",\"authors\":\"Raghu Vasanthan\",\"doi\":\"10.46889/jdr.2023.4104\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Terbinafine is a commonly used anti-fungal agent in dermatological practice but not one clearly associated with erythema nodosum. There is only one published report in 2014 that described a delayed onset of erythema nodosum after cholestasis complicated terbinafine therapy. We report the case of a woman who developed erythema nodosum whilst on terbinafine therapy for onychomycosis to further consider this link and its potential implications.\",\"PeriodicalId\":15448,\"journal\":{\"name\":\"Journal of clinical & experimental dermatology research\",\"volume\":\"63 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical & experimental dermatology research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.46889/jdr.2023.4104\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical & experimental dermatology research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46889/jdr.2023.4104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Erythema Nodosum Associated with Terbinafine Therapy- A Case Report
Terbinafine is a commonly used anti-fungal agent in dermatological practice but not one clearly associated with erythema nodosum. There is only one published report in 2014 that described a delayed onset of erythema nodosum after cholestasis complicated terbinafine therapy. We report the case of a woman who developed erythema nodosum whilst on terbinafine therapy for onychomycosis to further consider this link and its potential implications.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
